Transaction DateRecipientSharesTypePriceValue
26th January 2021Inc. Innoviva,1,867,912Open or private purchase$3.25$6,070,714.00
1st September 2020Inc. Innoviva,4,672,897Open or private purchase$2.68$12,499,999.48
11th June 2020Inc. Innoviva,12,677,490Open or private purchase$2.50$31,693,725.00
27th March 2020Inc. Innoviva,7,717,661Open or private purchase$2.87$22,149,687.07
Ampli Phi Biosciences
Ampli Phi Biosciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

. Develops and commercializes novel bacteriophage-based therapeutics. Developing and commercializing novel bacteria-based therapies for cancer and other diseases.

Ticker: APHB
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 921114
Employees: 31
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags